< Back to latest news & events

Knowledge Hub

UPC Prep Comm – Further progress, yet further delays

September 2017

The UPC Preparatory Committee has posted an update on the “Progress on the Unified Patent Court Project”.

Good progress was reported on the one hand, with 14 full ratifications and more in the pipeline. The UK for example, has laid a draft Scottish Statutory Instrument before Scottish Parliament – “The International Organisations (Immunities and Privileges) (Scotland) Amendment (No. 2) Order 2017”. The purpose of the instrument is to provide legal privileges and immunities on the Unified Patent Court its Judges, Representatives and Staff, so far as this is within devolved competence of the Scottish Parliament.  The SI is one of the last remaining legislative steps before the UPC Agreement can be ratified by the UK; it cites one of its objective as “being done in order to help secure compliance by the United Kingdom with its international obligations”.

On the other hand, it was also acknowledged that due to a case currently pending in the German Federal Constitutional Court (FCC) concerning the law passed by the German Parliament on the implementation of the Agreement on the Unified Patent Court (UPCA), delays to the German ratification of the UPCA and the Protocol on Provisional Application are expected.

The update ended by recognising that it is now “difficult to predict any timeline” for the UPC coming in to being.

Latest updates

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

Often Copied, Never Equaled: When Do Everyday Items Become Subject of Copyright?

The  borderline between ‘pure’ works of art and mere utilitarian objects” –  Can iconic, yet everyday products be protected under copyright? The above question was posed by Advocate General in …

Read article